Prolonged schemes of combined hormonal contraceptives assignment

Prolonged schemes of combined hormonal contraceptives assignment

This article is a review of continuous use of oral contraception.

Bibliographic Details
Main Authors:	V V Korennaya, K N Kayibkhanova, E A Liubimova, V V Agisheva
Format:	Article
Language:	Russian
Published:	IP Berlin A.V. 2015-06-01
Series:	Гинекология
Subjects:	combined oral contraception continuous prolonged use dienogest
Online Access:	https://gynecology.orscience.ru/2079-5831/article/viewFile/28428/pdf

Similar Items

Prolonged regimens for combined oral contraceptives
by: I V Kuznetsova
Published: (2017-02-01)

The personalized approach to choosing a contraceptive: weighing the pros and cons
by: Yu E Dobrokhotova, et al.
Published: (2017-06-01)

FIXED PROLONGED REGIME OF COMBINED ORAL CONTRACEPTIVES (COC) INTAKE IN SOLUTION OF CLASSIC CONTRACEPTION ISSUES (LITERATURE REVIEW)
by: V. N. Prilepskaya, et al.
Published: (2017-07-01)

Combined oral contraceptives with shortened hormone-free interval. Proven advantages of the therapy regime
by: G. B. Dikke
Published: (2019-10-01)

NEW MODE OF PROLONGED HORMONAL CONTRACEPTION
by: A. N. Mheryan, et al.
Published: (2017-10-01)

Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice
by: E. R. Dovletkhanova, et al.
Published: (2018-09-01)

Real clinical practice and contraception for young women with children
by: Natalia V. Aganezova, et al.
Published: (2021-03-01)

Administration of combined contraceptive containing dienogest and ethinyl estradiol for endometriosis
by: L. V. Yerofeyeva
Published: (2016-12-01)

Dysmenorrhea, endometriosis, adenomyosis: clinical and pathogenetic relationships
by: A.L.Unanian, et al.
Published: (2018-01-01)

Dysmenorrhea, endometriosis, adenomyosis: clinical and pathogenetic relationships
by: A L Unanian, et al.
Published: (2018-02-01)

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
by: Briggs P, et al.
Published: (2016-09-01)

HORMONAL CONTRACEPTION AS TREATMENT FOR ANOMALOUS UTERINE BLEEDING
by: I. V. Kuznetsova
Published: (2018-01-01)

Observational Study for Adverse Effects and Discontinuation with Long-Term Post-Operative Hormonal Treatment for Endometriosis in Real-World Practice
by: In Hye Kim, et al.
Published: (2021-12-01)

Effect of combined oral contraceptives with estrogen identical to natural estrogen on the metabolic profile and body composition in females during the menopausal transition
by: Veronika I. Komedina, et al.
Published: (2023-01-01)

Personified choice of hormonal contraception
by: L Yu Karakhalis
Published: (2018-08-01)

HORMONAL CONTRACEPTION AND MAGNESIUM DEFICIENCY: A SUBANALYSIS OF THE MAGYN STUDY
by: D. V. Blinov, et al.
Published: (2017-06-01)

Vaginal hormonal ring: a modern method for prolonged contraception
by: A. Z. Khashukoeva, et al.
Published: (2020-04-01)

Comparison of Combined Parenteral and Oral Hormonal Contraceptives: A Systematic Review and Meta-Analysis of Randomized Trials
by: Gábor Vleskó, et al.
Published: (2024-01-01)

Contraception with estradiol valerate and dienogest: adherence to the method
by: Fruzzetti F, et al.
Published: (2019-05-01)

The use of combined hormonal contraception in the context of the COVID-19 pandemic
by: A. T. Uruymagova, et al.
Published: (2021-10-01)

ADMINISTRATION OF A COMBINED ORAL CONTRACEPTIVE CONTAINING ESTRADIOL VALERATE/DIENOGEST (E2V/DNG) BY WOMEN WITH MENORRHAGIA
by: E. R. Dovlethanova, et al.
Published: (2017-12-01)

Combined oral contraceptives with natural estrogen and sexual function: the optimal method of contraception for women of different ages
by: Svetlana V Yureneva, et al.
Published: (2019-02-01)

Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain
by: Anjeza Xholli, et al.
Published: (2021-10-01)

Comprehensive assessment of efficacy, tolerability and safety of a third-generation combined hormonal contraceptive
by: E. A. Mezhevitinova, et al.
Published: (2015-12-01)

Treating endometriosis with hormonal contraceptives
by: L. Y. Karakhalis, et al.
Published: (2016-12-01)

Endometrial receptivity during hormonal therapy in women of reproductive age with abnormal uterine bleeding due to ovulatory disorders
by: Angelica R. Ten, et al.
Published: (2022-09-01)

Reproductive behavior of medical students: realities of contraceptive choice
by: T A Oboskalova, et al.
Published: (2018-06-01)

Complex questions about combined hormonal contraception: A review
by: Vera N. Prilepskaya, et al.
Published: (2023-07-01)

Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01)

Topical issues in combined oral contraceptives usage
by: S O Dubrovina
Published: (2018-04-01)

Influence of genetic polymorphisms on fibrinogen level at taking of combined oral contraceptives
by: D. R. Gamyrkina, et al.
Published: (2016-03-01)

Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis
by: Oyesanmi A. Fabunmi, et al.
Published: (2023-04-01)

Benefits of using combined oral contraceptive with drospirenone in 24+4 overweight adolescents
by: I V Kuznetsova, et al.
Published: (2014-02-01)

Noncontraceptive effects of combined oral contraceptives: benefits and risks of use
by: A L Unanyan, et al.
Published: (2017-04-01)

MENORRHAGIA: ARE THERE ANY SOLUTIONS?
by: Y. E. Dobrokhotova, et al.
Published: (2016-12-01)

Cancer risks and benefits of hormonal contraception: a literature review and practical issues
by: Antonina V Ledina, et al.
Published: (2019-02-01)

Emergency contraception: ¿how, when and with what?
by: Álvaro Monterrosa Castro
Published: (2006-04-01)

Risks of venous thromboembolic complications in related to combined oral contraceptives
by: K. A. Gabelova, et al.
Published: (2022-01-01)

Oral and Vaginal Hormonal Contraceptives Induce Similar Unfavorable Metabolic Effects in Women with PCOS: A Randomized Controlled Trial
by: Maria-Elina Mosorin, et al.
Published: (2023-04-01)

The effect of lavender on mood disorders associated with the use of combined oral contraceptives (COCs): a triple-blinded randomized controlled trial
by: Mina Naghdi, et al.
Published: (2024-03-01)